Quick Wrap: Nifty Pharma Index declines 0.83%

a day ago

Nifty Pharma index ended down 0.83% at 21970.15 today. The index is down 2.00% over last one month. Among the constituents, Biocon Ltd shed 2.63%, Abbott India Ltd dropped 2.18% and Divis Laboratories Ltd slipped 1.24%. The Nifty Pharma index is up 2.00% over last one year compared to the 2.47% surge in benchmark Nifty 50 index. In other indices, Nifty FMCG index is down 0.72% and Nifty IT index has dropped 0.48% on the day. In broad markets, the Nifty 50 has dropped 0.30% to close at 24649.55 while the SENSEX has dropped 0.38% to close at 80710.25 today.

Hashtags

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Indian bond yields spike 9 bps to 6.42% after RBI policy

Economic Times

3 hours ago

Economic Times

Indian bond yields spike 9 bps to 6.42% after RBI policy

(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

SIPs in equity mutual funds deliver steady gains despite market wobbles

Business Standard

5 hours ago

Business Standard

SIPs in equity mutual funds deliver steady gains despite market wobbles

Systematic investment plans (SIPs) in equity mutual funds have managed to post stable returns over the past year, as cost averaging helped investors ride out market turbulence. Over 50 per cent of the schemes in key active equity categories delivered more than 5 per cent return to SIP investors in the one-year period, according to data from Value Research. This performance comes despite the broader market showing little to no gains. The Nifty 50 index was flat for the one-year period ended August 4, while the NSE 500 slipped 1.7 per cent. As a result, one-time investment in most active equity schemes have not yielded much returns. The median one-year return from a lumpsum investment in the flexicap category stands at 4.3 per cent. Over the same period, median SIP returns in flexicap schemes are around 6 per cent. Retail participation held steady even during the correction between September 2024 and February 2025. Monthly SIP inflows hovered around ₹26,000 crore during that phase, and have hit fresh highs in the past three months. However, while contributions remained resilient, the correction did lead to a rise in SIP account closures. SIPs are the recommended route to invest in equity mutual funds, especially given the volatility. Experts cite advantages such as rupee-cost averaging and investing discipline. 'Investors who have been disciplined in taking the SIP route to regularly invest have done better,' said Aditya Khemani, fund manager–equity, Invesco India Mutual Fund. 'While the short-term outcome is difficult to predict, SIP investments with a longer-term view are likely to generate better returns.' Still, fund selection proved critical. Of the 250 schemes across flexicap, largecap, smallcap, large & midcap, midcap, multicap, focused, and ELSS categories, 26 delivered over 10 per cent SIP returns over the past year. At the same time, 20 schemes in these categories posted negative returns.

NDR InvIT Trust reports strong revenue growth and operational expansion in Q1 FY26

Economic Times

6 hours ago

Economic Times

Quick Wrap: Nifty Pharma Index declines 0.83%

Hashtags

Try Our AI Features

Comments

Related Articles

Indian bond yields spike 9 bps to 6.42% after RBI policy

SIPs in equity mutual funds deliver steady gains despite market wobbles

NDR InvIT Trust reports strong revenue growth and operational expansion in Q1 FY26

Get Started Now: Download the App